WCM
ACOR

Wealthcare Capital Management’s Acorda Therapeutics ACOR Stock Holding History

Wealthcare Capital Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10
Closed – – 906
2015
Q1 		$0 Buy
+10
New +$45.8K ﹤0.01% 1030

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wealthcare Capital Management's ACOR Position: Q2 2015 in Review

Wealthcare Capital Management sold out of Acorda Therapeutics (ACOR) in Q2 2015, closing a stake of 10 shares.

Wealthcare Capital Management first reported a position in ACOR in Q1 2015 and held it in 1 quarter. The position peaked at $0 in Q1 2015. 170 funds tracked by Wall St. Rank hold ACOR as of Q2 2015.

  • Wealthcare Capital Management reported no remaining Acorda Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Wealthcare Capital Management sold 10 Acorda Therapeutics shares in Q2 2015.
  • Wealthcare Capital Management first reported a position in Acorda Therapeutics in Q1 2015 and held it in 1 quarter.
  • Wealthcare Capital Management's Acorda Therapeutics position peaked at $0 in Q1 2015.
  • 170 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2015.

Based on Wealthcare Capital Management's 13F filing for Q2 2015, filed 24 Aug 2015.